Trial intelligence / Profile preview

Individualized perioperative hemodynamic goal-directed therapy in major abdominal surgery (iPEGASUS)

2017-001479-22Phase 4Active

Sponsor
University Medical Center Hamburg-Eppendorf
Start
Jul 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of norepinephrine and dobutamine in Cardiovascular collapse and cardiovascular dysfunction, sponsored by University Medical Center Hamburg-Eppendorf. Primary endpoint: Postoperative morbidity (primary). Started Jul 2017; status: active.

02

Drugs

norepinephrinedobutamine
03

Conditions

Cardiovascular collapsecardiovascular dysfunction

Beyond the preview

Go deeper on 2017-001479-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-001479-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call